In order to assess the relation between CT60 cytotoxic T lymphocyte antigen-4 (CTLA-4)

gene polymorphism and thyroid autoantibody production, we investigated 180 consecutive newly diagnosed patients with two forms of AITD, 105 with Hashimoto’s thyroiditis (HT) and 75 with postpartum thyroiditis (PPT). We evaluated thyroid function, measured antibodies against thyroid selleck inhibitor peroxidase (TPO) and thyroglobulin (Tg), and determined CT60 CTLA-4 gene polymorphism. In HT, TPO antibody median value was significantly lower in the AA compared to the AG and GG genotypes (65, 122 and 319 U/ml, P < 0·005), while the Tg antibody median value was lower in the AA compared to the AG genotype (91 and 189 U/ml, P < 0·02). In PPT, the frequency of thyroid autoantibody-positive patients was higher among G-allele-carrying

genotypes (P < 0·04). Similar selleck chemical to HT, the TPO antibody median value was lower in the AA compared to the AG and GG genotypes (12, 130 and 423 U/ml, P < 0·006). Hypothyroid PPT patients were more often thyroid autoantibody-positive (P < 0·005) and the TPO antibody median value was higher compared to hyperthyroid PPT patients (500 and 32 U/ml, P < 0·0001). The frequency of the G-allele was significantly higher among hypothyroid patients (P < 0·05). Our data suggest that in both HT and PPT, the CT60 CTLA-4 gene polymorphism contributes importantly to thyroid autoantibody production. In PPT, the genotype also seems to influence thyroid function, as patients with the polymorphous allele are more prone to develop hypothyroid form of PPT. The presence of circulating autoantibodies against major thyroid antigens is the hallmark of thyroid autoimmunity, which comprises several different clinical forms, including Hashimoto's thyroiditis (HT) and postpartum thyroiditis (PPT). In HT, the antibodies against thyroid peroxidase or thyroglobulin (Tg) appear characteristically in the patients' sera, while tissue damage due to T cell-mediated cytotoxicity usually contributes to gradual development of hypothyroidism [1]. In PPT, where the re-establishment of immune responsiveness

after delivery leads to thyroid dysfunction in the first year postpartum, two-thirds of females present with RG7420 in vivo positive thyroid peroxidase antibodies, putting them at risk for developing a hypothyroid form of PPT and permanent hypothyroidism. Thyroid peroxidase antibody-negative PPT patients are more likely to experience only a phase of transient hyperthyroidism and 1 year postpartum the euthyroid state is usually restored [2]. Similar to autoimmune thyroid disease (AITD), strong genetic susceptibility is required for the production of thyroid autoantibodies [3]. According to an estimation based on Danish twin pairs, the genetic background contributes 73% to the predisposition to thyroid autoantibody production [4].